PMID: 15357938Sep 11, 2004Paper

Antibiotic resistance in clinical isolates of Pseudomonas aeruginosa in Jamaica

Revista Panamericana De Salud Pública = Pan American Journal of Public Health
P D Brown, Anicetus Izundu

Abstract

To assess antibiotic resistance in clinical isolates of Pseudomonas aeruginosa in Jamaica, and to obtain baseline information on the presence of this important pathogen. A total of 51 isolates of Pseudomonas aeruginosa, obtained from 162 clinical specimens from major hospitals and laboratories in seven parishes in Jamaica, were analyzed between May and August 2002. Isolates were tested against 18 different antibiotics by a disk diffusion method. Organisms were cultured from wound swabs (56%), high vaginal swabs (10.5%) and ear swabs (42.5%). Overall, the highest percentage rates of resistance were found for cefaclor (100% of all isolates), nalidixic acid (82.4%), kanamycin (76.5%), and trimethoprim/sulfamethoxazole (56.9%). Resistance rates were 25.5% or lower for tobramycin, gentamicin and polymyxin B, cefotaxime, ciprofloxacin and norfloxacin, piperacillin, carbapenems and amikacin. Forty-one isolates showed intermediate sensitivity to most of the antipseudomonal antibiotics, and the remaining 10 isolates were resistant to eight or more antibiotics. The multiresistant isolates, most of which were hospital isolates, were all resistant to tetracycline, nalidixic acid and trimethoprim/sulfamethoxazole, and highly (80%-90%) resis...Continue Reading

Citations

Oct 14, 2010·International Journal of Biological Sciences·Premkumar JayaramanKishore R Sakharkar
May 1, 2010·Journal of Drug Targeting·Premkumar JayaramanMeena K Sakharkar
Feb 26, 2016·Journal of Food Science·Marilù DecimoMilena Brasca
Jul 4, 2006·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Paul D Brown, Charles Ngeno
Jun 6, 2006·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Jaffar A Al-Tawfiq
May 7, 2009·FEMS Microbiology Reviews·Sarah O'FlahertyAidan Coffey
Jul 26, 2012·International Journal of Environmental Research and Public Health·Emmanuel E OdjadjareAnthony I Okoh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

The New England Journal of Medicine
S BlotF Colardyn
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Robert R MuderVictor L Yu
The New England Journal of Medicine
W Brumfitt, J M Hamilton-Miller
© 2021 Meta ULC. All rights reserved